From the Departments of Radiodiagnosis (D.K., M.J.) and Paediatrics (R.M., R.S.), All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India 110029.
Radiology. 2022 Dec;305(3):746-750. doi: 10.1148/radiol.211119.
An 11-year-old girl presented to the pediatric gastroenterology outpatient department of our institution with gradually increasing painless abdominal distention. The distention started 2 years earlier and was not associated with any other constitutional symptoms, vomiting, diarrhea, jaundice, hematemesis, or melaena. She reported early satiety and heaviness in the lower abdomen. The abdominal swelling was predominantly in the infraumbilical region and was soft at palpation. She was the first child of nonconsanguineous parents and had an uneventful perinatal course after a normal vaginal delivery. Her developmental milestones were normal. She had an average scholastic performance at school. There was no history of visual problems, seizures, or inappropriate behaviors. She had an early menarche 2 years previously. Her menstrual cycles were regular, and there was no abnormal vaginal discharge. Her breast development was normal (Tanner stage III), while pubic and axillary hair were absent (Tanner stage I). She was short for her age (104 cm; normal range, 120-154 cm). There was no history of short stature among her siblings or parents. Laboratory investigations were performed to measure thyroid-stimulating hormone (1354.34 µIU/mL; normal range, 0.35-5.5 µIU/mL), triiodothyronine (<2.5 ng/dL [0.0385 pmol/L]; normal range, 100-200 ng/dL [1.54-3.08 pmol/L]), thyroxine (1.35 µg/dL [17.37 nmol/L]; normal range, 5-12 µg/dL [64.35-154.44 nmol/L]), β-human chorionic gonadotropin (<1.2 mIU/mL; normal, <5 mIU/mL), luteinizing hormone (0.08 mIU/mL; normal range, 0.1-6.0 mIU/mL), and follicle-stimulating hormone (6.93 mIU/mL; normal range, 0.3-2.0 mIU/mL) levels. Complete blood count was normal. An abdominal mass was suspected, and abdominopelvic CT was performed and followed by US; these examinations revealed multiple large cysts in both ovaries. The uterus was pubertal in shape, and endometrial thickness was 9 mm, representing normal follicular phase measurement. Serum CA-125 and inhibin levels were normal. To evaluate short stature, radiographs of the hand and pelvis were obtained as part of a limited skeletal survey, keeping in mind the possible skeletal changes associated with hypothyroidism. In view of the hypothyroidism, US of the neck was also performed. Treatment was started based on the clinical and radiologic parameters, and the child's condition improved with medical treatment.
一位 11 岁女孩因进行性无痛性腹胀到我院儿科胃肠病门诊就诊。腹胀始于 2 年前,无其他全身症状、呕吐、腹泻、黄疸、呕血或黑便。她诉有早饱感和下腹部沉重感。腹部肿胀主要位于脐下区域,触诊时柔软。她是无血缘关系父母的第一个孩子,正常阴道分娩后围产期无异常。她的发育里程碑正常。她在学校的学习成绩中等。无视觉问题、癫痫或行为异常史。她 2 年前初潮。月经周期规律,无异常阴道分泌物。她的乳房发育正常(Tanner Ⅲ期),而阴毛和腋毛缺失(Tanner Ⅰ期)。她的身高低于年龄(104cm;正常范围 120-154cm)。她的兄弟姐妹或父母中没有身材矮小的病史。进行了甲状腺刺激激素(1354.34µIU/mL;正常范围 0.35-5.5µIU/mL)、三碘甲状腺原氨酸(<2.5ng/dL[0.0385pmol/L];正常范围 100-200ng/dL[1.54-3.08pmol/L])、甲状腺素(1.35µg/dL[17.37nmol/L];正常范围 5-12µg/dL[64.35-154.44nmol/L])、β-人绒毛膜促性腺激素(<1.2mIU/mL;正常<5mIU/mL)、黄体生成素(0.08mIU/mL;正常范围 0.1-6.0mIU/mL)和卵泡刺激素(6.93mIU/mL;正常范围 0.3-2.0mIU/mL)水平的实验室检查。全血细胞计数正常。怀疑存在腹部肿块,进行了腹部盆腔 CT 检查,随后进行了 US;这些检查显示双侧卵巢有多个大囊肿。子宫呈青春期形状,子宫内膜厚度为 9mm,代表正常卵泡期测量值。血清 CA-125 和抑制素水平正常。为评估身材矮小,作为有限骨骼检查的一部分,拍摄了手部和骨盆的 X 光片,同时考虑与甲状腺功能减退相关的可能骨骼变化。鉴于甲状腺功能减退,还进行了颈部 US。根据临床和影像学参数开始治疗,患儿病情在药物治疗后得到改善。